Patients' perspectives of telemedicine appointments for psoriatic arthritis during the COVID-19 pandemic: results of a patient-driven pilot survey

Hannah Jethwa; Melanie Brooke; Andrew Parkinson; Emma Dures; Nicola J Gullick

doi:10.1186/s41927-021-00242-y

Patients' perspectives of telemedicine appointments for psoriatic arthritis during the COVID-19 pandemic: results of a patient-driven pilot survey

BMC Rheumatol. 2022 Feb 22;6(1):13. doi: 10.1186/s41927-021-00242-y.

Authors

Hannah Jethwa^#¹, Melanie Brooke^#², Andrew Parkinson^#³, Emma Dures⁴, Nicola J Gullick⁵

Affiliations

¹ Department of Rheumatology, Hammersmith Hospital, 72 Du Cane Road, London, W12 0HS, UK. hannahjethwa@nhs.net.
² , Bath, UK.
³ , Leeds, UK.
⁴ Academic Rheumatology, Bristol Royal Infirmary and Centre for Healthcare and Clinical Research, University of West of England, Bristol, UK.
⁵ Department of Rheumatology, University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK.

^# Contributed equally.

Abstract

Background: Over recent years the lack of patient involvement in the design, set-up and implementation of clinical research studies has been well recognised; as such there has been a drive within research communities to increase patient participation. Patient perspectives on telemedicine differ widely, with variation in whether patients feel remote consultations are beneficial. By means of a patient-driven survey, we aimed to formally evaluate patient perspectives on its benefits and pitfalls, focusing on patients with psoriatic arthritis (PsA).

Methods: An e-survey was developed by two patient representatives on the BritPACT steering committee, with a view to determining unmet needs and the perceived impact on clinical care of virtual consultations amongst patients with PsA.

Results: 128 patients responded to the e-survey. 109 patients rated the effectiveness of their telemedicine appointment and, of these, 18% felt their virtual consultation was very/extremely effective compared to an in-clinic consultation and 49% felt it was somewhat/equally as effective; furthermore, 48% (51/107) felt that such virtual consultations would be of benefit to them after the pandemic. 36% of respondents felt their virtual consultation was not as effective as an in-clinic review. Themes identified from open-ended questions included the lack of visual cues, lack of physical examination and effect on rapport and ease of open communication as the main pitfalls of virtual consultations. Patients with well-controlled symptoms appeared more satisfied with remote reviews compared to those with active disease, though on the whole respondents recognised the benefits, such as saving travel time and costs. Those who had an established relationship with their health professional appeared less concerned regarding virtual consultations though a recurring view was that newly diagnosed patients should have in-clinic appointments to build rapport and improve symptom control at an early stage.

Conclusions: Overall patients' perspectives on virtual consultations varied widely though patients with well-controlled symptoms and those who had a previously established relationship with their healthcare professionals and well-controlled disease appeared more satisfied with remote reviews.

Keywords: Patient perspectives; Psoriatic arthritis; Rheumatology; Telemedicine.